Please confirm topic selection

Are you sure you want to trigger topic in your Anconeus AI algorithm?

Please confirm action

You are done for today with this topic.

Would you like to start learning session with this topic items scheduled for future?

Updated: Dec 26 2021

Oligodendrogliomas

Images
https://upload.medbullets.com/topic/422782/images/oligodendroglioma_flair..jpg
https://upload.medbullets.com/topic/422782/images/oligodendroglioma.jpg
  • Snapshot
    • A 47-year-old man presents to the emergency department complaining of a headache. His symptoms have been progressively worsening over the course of week. He does not have a past medical history of headaches and has noticed some weakness in his left upper extremity. Physical examination is notable for 4/5 power throughout the left upper extremity. MRI brain with gadolinium demonstrates a white matter mass lesion with patchy enhancement. Neurosurgery is consulted for surgical resection.
  • Introduction
    • Definition
      • malignant tumor arise from oligodendrocytes
        • most commonly affects the frontal and temporal lobe and is slow growing
  • ETIOLOGY
    • Pathophysiology
      • genetic mutations lead to dysregulated and abnormal cellular proliferation
  • Epidemiology
    • Demographics
      • typically 25-45 years of age
  • Presentation
    • Symptoms/physical exam
      • clinical manifestations depend on where the tumor arises from
      • seizure
      • headaches
      • personality changes
  • Imaging
    • MRI brain with and without contrast
      • indication
        • imaging study of choice
      • findings
        • enhancing mass
          • calcifications are characteristic
          • absence of contrast enhancement does not exclude the diagnosis
  • Studies
    • Histopathology and molecular testing
      • indication
        • confirms the diagnosis
      • findings
        • histopathology
          • "fried egg" cellular appearance
            • round nuclei within a clear cytoplasm
        • molecular testing
          • IDH1 or IDH2 mutation and 1p/19q co-deletion
  • Differential
    • Other malignant brain neoplasm
      • differentiating factors
        • based on histological findings
          • e.g., glioblastomas will have pleomorphic tumor cells surrounding a central area of necrosis
  • Treatment
    • Surgical
      • resection
        • indication
          • initial step in management
            • obtain tissue for histopathology and molecular testing
            • radiation therapy and chemotherapy is typically given as well
  • Complications
    • Seizures
    • Neurological deficits
  • Prognosis
    • Poor
Card
1 of 0
Private Note